Arab Drug Company for Pharmaceuticals and Chemical Industries SAE operates in the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arab Drug Company for Pharmaceuticals and Chemical Industries SAE with three other pharmaceutical manufacturers in Middle East: Oramed Pharmaceuticals Incorporation of ISRAEL (2020 sales of 9.40 million Israel Shekels [US$2.87 million] ), Memphis Pharmaceuticals and Chemical Industries SAE (490.10 million Egyptian Pounds [US$31.34 million] ), and El Nile Company for Pharmaceuticals and Chemical Industries SAE (812.54 million Egyptian Pounds [US$51.96 million] ).

Sales Analysis. Arab Drug Company for Pharmaceuticals and Chemical Industries SAE reported sales of 521.07 million Egyptian Pounds (US$33.32 million) for the fiscal year ending June of 2020. This represents an increase of 19.4% versus 2019, when the company's sales were 436.35 million Egyptian Pounds. Sales at Arab Drug Company for Pharmaceuticals and Chemical Industries SAE have increased during each of the previous five years (and since 2015, sales have increased a total of 133%).